Logo image of AVNT.CA

AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis

TSX:AVNT - Toronto Stock Exchange - CA05353D2023 - Common Stock - Currency: CAD

0.77  -0.01 (-1.28%)

Fundamental Rating

2

Taking everything into account, AVNT scores 2 out of 10 in our fundamental rating. AVNT was compared to 35 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of AVNT have multiple concerns. AVNT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AVNT has reported negative net income.
AVNT had a positive operating cash flow in the past year.
AVNT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AVNT reported negative operating cash flow in multiple years.
AVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFAVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -36.78%, AVNT is doing worse than 80.00% of the companies in the same industry.
AVNT has a Return On Equity of -64.82%. This is in the lower half of the industry: AVNT underperforms 71.43% of its industry peers.
AVNT has a better Return On Invested Capital (4.81%) than 85.71% of its industry peers.
Industry RankSector Rank
ROA -36.78%
ROE -64.82%
ROIC 4.81%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
AVNT.CA Yearly ROA, ROE, ROICAVNT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

AVNT's Operating Margin of 7.96% is fine compared to the rest of the industry. AVNT outperforms 74.29% of its industry peers.
The Gross Margin of AVNT (39.54%) is comparable to the rest of the industry.
AVNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.96%
PM (TTM) N/A
GM 39.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
AVNT.CA Yearly Profit, Operating, Gross MarginsAVNT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVNT is destroying value.
Compared to 1 year ago, AVNT has more shares outstanding
AVNT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AVNT has a worse debt to assets ratio.
AVNT.CA Yearly Shares OutstandingAVNT.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
AVNT.CA Yearly Total Debt VS Total AssetsAVNT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.95, we must say that AVNT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.95, AVNT perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
The Debt to FCF ratio of AVNT is 51.56, which is on the high side as it means it would take AVNT, 51.56 years of fcf income to pay off all of its debts.
AVNT has a Debt to FCF ratio (51.56) which is comparable to the rest of the industry.
AVNT has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
AVNT's Debt to Equity ratio of 0.35 is in line compared to the rest of the industry. AVNT outperforms 54.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 51.56
Altman-Z -0.95
ROIC/WACC0.68
WACC7.08%
AVNT.CA Yearly LT Debt VS Equity VS FCFAVNT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.86 indicates that AVNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.86, AVNT is in line with its industry, outperforming 54.29% of the companies in the same industry.
AVNT has a Quick Ratio of 1.06. This is a normal value and indicates that AVNT is financially healthy and should not expect problems in meeting its short term obligations.
AVNT has a Quick ratio (1.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.06
AVNT.CA Yearly Current Assets VS Current LiabilitesAVNT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AVNT have decreased strongly by -125.63% in the last year.
Looking at the last year, AVNT shows a very strong growth in Revenue. The Revenue has grown by 32.63%.
AVNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 72.25% yearly.
EPS 1Y (TTM)-125.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.71%
Revenue 1Y (TTM)32.63%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%6.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVNT.CA Yearly Revenue VS EstimatesAVNT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVNT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVNT.CA Price Earnings VS Forward Price EarningsAVNT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AVNT indicates a rather cheap valuation: AVNT is cheaper than 97.14% of the companies listed in the same industry.
62.86% of the companies in the same industry are more expensive than AVNT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.95
EV/EBITDA 3.23
AVNT.CA Per share dataAVNT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANT BRANDS INC

TSX:AVNT (6/11/2025, 7:00:00 PM)

0.77

-0.01 (-1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-14 2025-04-14
Earnings (Next)07-14 2025-07-14
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.55%
Ins Owner ChangeN/A
Market Cap8.33M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF 25.95
P/OCF 19.42
P/B 0.26
P/tB 0.27
EV/EBITDA 3.23
EPS(TTM)-2.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY3.85%
OCF(TTM)0.04
OCFY5.15%
SpS3.36
BVpS2.95
TBVpS2.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.78%
ROE -64.82%
ROCE 6.68%
ROIC 4.81%
ROICexc 4.92%
ROICexgc 5.08%
OM 7.96%
PM (TTM) N/A
GM 39.54%
FCFM 0.88%
ROA(3y)-18.44%
ROA(5y)-20.49%
ROE(3y)-32.03%
ROE(5y)-31.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 51.56
Debt/EBITDA 1.53
Cap/Depr 2.4%
Cap/Sales 0.3%
Interest Coverage 250
Cash Conversion 5.81%
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.06
Altman-Z -0.95
F-Score3
WACC7.08%
ROIC/WACC0.68
Cap/Depr(3y)30.6%
Cap/Depr(5y)37.88%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-125.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.63%
Revenue growth 3Y55.63%
Revenue growth 5Y72.25%
Sales Q2Q%6.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y213.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.58%
OCF growth 3YN/A
OCF growth 5YN/A